Vivos Inc (RDGL): R&D Expense
$352.2K
Year ended 2025-12-31
$212.1K
Trailing 12 months to 2026-06-30
+0.8%
3-year compound annual growth
+33.0%
5-year compound annual growth
+8.9%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $352.2K | +8.5% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $324.6K | -55.7% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $732.7K | +113.1% | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | $343.8K | +19.9% | 2024-03-18, From 2022-01-01 |
| 2021-12-31 | $286.8K | +238.8% | 2023-03-01, From 2021-01-01 |
| 2020-12-31 | $84.7K | +25.3% | 2022-03-07, From 2020-01-01 |
| 2019-12-31 | $67.6K | -35.1% | 2021-03-24, From 2019-01-01 |
| 2018-12-31 | $104.2K | -48.7% | 2020-04-28, From 2018-01-01 |
| 2017-12-31 | $203.0K | -38.1% | 2019-03-25, From 2017-01-01 |
| 2016-12-31 | $328.0K | +119.2% | 2018-04-02, From 2016-01-01 |
| 2015-12-31 | $149.7K | +238.1% | 2018-01-25, From 2015-01-01 |
| 2014-12-31 | $44.3K | n/a | 2016-05-26, From 2014-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Vivos Inc (RDGL) | 2025-12-31 | $352.2K | +8.5% |
| QTREX Quantum Ltd. (QTEX) | 2025-12-31 | $7.50M | +18.6% |
| Pulse Biosciences, Inc. (PLSE) | 2025-12-31 | $44.72M | +38.3% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $19.14M | -8.8% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $2.65M | +14.8% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $862.0K | +216.9% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $4.59M | -11.8% |
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $6.27M | +4.0% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.42M | -10.6% |
Compare RDGL, QTEX, PLSE, CODX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗